Suppr超能文献

[心脏瓣膜假体与妊娠]

[Heart valve prosthesis and pregnancy].

作者信息

Ben-Ismail M, Fekih M, Taktak M, Chelli M

出版信息

Arch Mal Coeur Vaiss. 1979 Feb;72(2):192-9.

PMID:107900
Abstract

Sixteen pregnancies were followed up in 13 patients with prosthetic heart valves: 8 pregnancies went to term under oral anticoagulation, 4 under heparin and 4 without anticoagulation. 9 healthy normal children were delivered; there were 2 still births and 5 abortions. On the maternal side 3 haemorrhages and thromboembolic episodes which involved 2 patients on heparin, one of whom died, were observed. The following points are apparent from our observations and a review of the existing medical literature: --the risk of thromboembolism is not increased. The marked clotting tendency of maternal blood post-partum contraindicates the withdrawal of anticoagulants during this critical period; --haemorrhagic complications are common with anticoagulants; --foetal loss is greatly increased; --the teratogenecity of vitamin-K antagonists is certain, but the risk is small. The problems of anticoagulation are discussed; theoretically heparin should be given during the 1st trimestre and from the 38th week to the second post-partum week. The patients should be closely supervised by both obstetrician and cardiologist and hospitalisation is advised for the last month of pregnancy. Normal vaginal delivery is usually possible.

摘要

对13例人工心脏瓣膜患者的16次妊娠进行了随访:8例在口服抗凝剂情况下足月分娩,4例在肝素抗凝下足月分娩,4例未进行抗凝。共分娩出9名健康正常婴儿;有2例死产和5例流产。在母亲方面,观察到3例出血和血栓栓塞事件,其中2例接受肝素治疗的患者发生此类情况,其中1例死亡。从我们的观察以及对现有医学文献的回顾中可以明显看出以下几点:——血栓栓塞风险并未增加。产后母亲血液明显的凝血倾向表明在此关键时期不应停用抗凝剂;——抗凝剂常见出血并发症;——胎儿丢失显著增加;——维生素K拮抗剂的致畸性是肯定的,但风险较小。讨论了抗凝问题;理论上,应在妊娠第一期以及从第38周开始至产后第二周给予肝素。患者应由产科医生和心脏病专家密切监护,建议在妊娠最后一个月住院。通常可以进行正常阴道分娩。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验